Advancement of Degraders Targeting Key Chromatin Regulators Involved in Disease/Oncology

Time: 9:30 am
day: Day 1

Details:

  • Progressing selective degradation of CBP and EP300 and their respective preclinical programs
  • Highlighting planned expansion of Foghorn TPD platform and portfolio

Speakers: